O(2)-ethylthymidine: formed by treatment of rat liver DNA by diethylnitrosamine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 124683 |
| MeSH ID | M0071787 |
| Synonym |
|---|
| o2-et-dt |
| 2-ethoxy-1-[(4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-4-one |
| 59495-21-5 |
| o(2)-ethylthymidine |
| o(2)-ethyldeoxythymidine |
| 4(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-2-ethoxy-5-methyl- |
| 1-(2-deoxypentofuranosyl)-2-ethoxy-5-methylpyrimidin-4(1h)-one |
| DTXSID60974894 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.38) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||